Rutgers, The State University of New Jersey: Autism Spectrum Disorder trials
The registry lists 10 Autism Spectrum Disorder studies with Rutgers, The State University of New Jersey as lead sponsor. 2 are open to participants now and 1 have results posted.
Phase 2 2No phase 8(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Emergent Multi-Class Imitation TrainingRecruitingNCT05849376Not applicable
- Validation Digital Bio-markers During Sulforaphane Treatment.Enrolling by invitationNCT04805957Not applicable
- Propranolol for Challenging Behaviors in AutismCompletedNCT04047355Phase 2Results posted
- Adapting BA for Minimally Verbal Autistic AdultsCompletedNCT06064422Not applicable
- Non-invasive Brain Stimulation in Children With AutismWithdrawnNCT05105126Not applicable
- Adaptation of a Behavioral Activation Treatment to Treat Depression in Autistic AdultsCompletedNCT05030610Not applicable
- Developing Mental Health Supports for Autistic StudentsCompletedNCT04926090Not applicable
- Transdiagnostic Group Behavioral Activation for Autistic AdultsCompletedNCT04788212Not applicable
- ASD (Autism Spectrum Disorder) Telehealth for Distress Related to COVID-19CompletedNCT04460677Not applicable
- Sulforaphane in a New Jersey (NJ) Population of Individuals With AutismActive, not recruitingNCT02677051Phase 2